title: Breast cancer in Western Australia in 1989. II. Diagnosis and primary management.
abstract: This study was designed as a population-based study of all cases of breast cancer diagnosed in Western Australia (WA) in 1989. Cases were identified from the State Cancer Registry and from computerized hospital inpatient records. Data were obtained from the records of surgeons and oncologists managing the patients, hospital medical records and pathology and cytology reports. A total of 701 tumours in 692 women were treated by 105 different surgeons of whom 25 saw 10 or more cases. Over 70% were proven by cytology or biopsy within 2 weeks of presentation to a doctor. The first diagnostic investigation was fine needle aspiration in 45%, open biopsy in 28% and diagnostic mammogram in 24.4%. A definitive procedure involving breast conservation was performed in 31.3% of patients with operable tumours; 35.6% of those under 50 years of age. If axillary dissection or sampling was part of such treatment, 93.5% of those under 50 years and 75% of those 50 years and over had radiotherapy to the residual breast. Although less than one-third of patients were referred to a medical oncologist almost a half had adjuvant systemic therapy (92% of node positive and 23% of node negative patients). Tamoxifen was prescribed as part of adjuvant therapy in 93% of those over 50 years and cyclophosphamide, methotrexate and 5-fluorouracil in 71% of those under 50 years. Less than 10% of patients treated with mastectomy and axillary dissection had postoperative radiotherapy to the chest wall and drainage areas. The patterns of care of patients with breast cancer in WA prior to the introduction of population-based mammographic screening have been established.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medical Oncology, Sir Charles Gairdner Hospital, Western Australia.
authors.forename: M J
authors.initials: MJ
authors.lastname: Byrne
authors.forename: K
authors.initials: K
authors.lastname: Jamrozik
authors.forename: R W
authors.initials: RW
authors.lastname: Parsons
authors.forename: C J
authors.initials: CJ
authors.lastname: Fitzgerald
authors.forename: J M
authors.initials: JM
authors.lastname: Dewar
authors.forename: J M
authors.initials: JM
authors.lastname: Harvey
authors.forename: G F
authors.initials: GF
authors.lastname: Sterrett
authors.forename: D M
authors.initials: DM
authors.lastname: Ingram
authors.forename: H J
authors.initials: HJ
authors.lastname: Sheiner
authors.forename: F G
authors.initials: FG
authors.lastname: Cameron
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001315:Australia; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008408:Mastectomy; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D013629:Tamoxifen; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate